Filter
7548
Filtered Results: 7548
Text search:
World
Health
Organization
WHO
(Africa)
Featured
Recommendations
672
New Publications
1694
Language
Document type
No document type
3962
Studies & Reports
1571
Guidelines
857
Manuals
366
Strategic & Response Plan
292
Fact sheets
187
Training Material
119
Situation Updates
80
Resource Platforms
33
Infographics
27
Online Courses
23
Brochures
17
Dashboards/Maps
6
Videos
5
App
3
Countries / Regions
Global
389
Kenya
246
South Africa
242
Sierra Leone
204
Africa
195
Nigeria
186
Liberia
181
Ethiopia
176
Uganda
164
Zambia
130
Malawi
125
Tanzania
115
Rwanda
112
Ghana
106
India
106
Congo, Democratic Republic of
102
Middle East and North Africa
101
Latin America and the Carribbean
97
Namibia
91
West and Central Africa
90
Mozambique
86
Syria
80
South Sudan
78
East and Southern Africa
75
Western and Central Europe
71
Guinea
70
Lesotho
65
Senegal
64
Zimbabwe
63
Yemen
60
Nepal
59
Burkina Faso
49
Bangladesh
47
Russia
40
Cameroon
39
Ukraine
37
Botswana
37
Asia
34
Central African Republic
34
Myanmar / Burma
32
Brazil
31
Mali
31
Benin
30
South–East Asia Region
30
Sudan
30
Colombia
28
Angola
27
Indonesia
27
Eswatini/ Swaziland
27
Haiti
26
Eastern Europe
26
China
23
Somalia
23
Madagascar
23
Côte d’Ivoire / Ivory Coast
22
Cambodia
21
Venezuela
20
Germany
19
Philippines
17
Chad
17
Pakistan
17
Afghanistan
16
Guinea-Bissau
16
Thailand
13
Eastern Europe and Central Asia
13
Vietnam
12
Niger
11
Togo
10
Lebanon
10
Burundi
9
Jordan
9
North America
9
Iraq
9
Chile
8
Iran
8
Saudi Arabia
8
Southern Africa
8
Sri Lanka
8
Libya
8
Mexico
7
Gambia
7
Peru
7
Western Pacific Region
7
Paraguay
7
Egypt
7
Ecuador
7
Tunisia
6
Papua New Guinea
6
Morocco
5
Jamaica
5
Japan
5
Portugal
5
Albania
4
Laos
4
Mauritania
4
Greece
4
Palestine
4
Georgia
4
North Macedonia
3
Tajikistan
3
Serbia
3
Turkey
3
Kazakhstan
3
Kyrgyzstan
3
Malaysia
3
Qatar
3
USA
3
Gabon
3
France
3
Mauritius
3
Spain
3
Israel
3
Bosnia and Herzegovina
3
Argentina
3
Moldova
3
Djibouti
3
El Salvador
2
Canada
2
Congo-Brazzaville
2
Italy
2
Armenia
2
Turkmenistan
2
Belarus
2
Bolivia
2
Honduras
2
North Korea
1
Timor Leste/ East Timor
1
Estonia
1
Vanuatu
1
Mongolia
1
Bulgaria
1
Dominican Republic
1
Cape Verde
1
Croatia
1
Hungary
1
Uruguay
1
Denmark
1
Belgium
1
United Kingdom
1
Norway
1
Algeria
1
Morocco
1
Azerbaijan
1
Eritrea
1
Nicaragua
1
Romania
1
Poland
1
Solomon Islands
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2570
Clinical Guidelines
582
Public Health
411
Key Resources
406
Women & Child Health
402
Capacity Building
133
Pharmacy & Technologies
81
Annual Report MEDBOX
2
Toolboxes
HIV
714
COVID-19
650
Mental Health
487
TB
421
Ebola & Marburg
345
NTDs
310
Disability
306
Planetary Health
293
Rapid Response
232
AMR
179
Caregiver
177
Global Health Education
172
Conflict
146
NCDs
141
Health Financing Toolbox
139
Refugee
129
Malaria
127
Pharmacy
115
Natural Hazards
63
Zika
56
Polio
47
Cholera
42
Social Ethics
27
Specific Hazards
23
2.0 Rapid Response
22
Typhoon
3
South Sudan
2
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Pillar 3 of the Global technical strategy for malaria 2016–2030 calls for the transformation of malaria surveillance into a core intervention in all malaria-endemic countries, as well as in countries which have eliminated malaria but remain susceptible to re-establishment of transmission. This ref...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
This is the first part of a five-part package that provides guidance on caregiver skills training for families of children aged 2–9 years with developmental delays or disabilities.
The Caregiver skills training for families of children with developmental delays or disabilities (CST) aims to pro...
Psychological first aid: Guide for field workers
recommended
When terrible things happen in our communities, countries and the world, we want to reach out a helping hand to those who are affected. This guide covers
psychological first aid which involves humane, supportive and practical help to fellow human beings suffering serious crisis events. It is writt...
The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of the second tripartite self-assessment survey
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
1 February 2021 to 31 January 2022
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Groupe indépendant d’experts de la redevabilité de l’initiative Chaque femme, chaque enfant. (2020). Dans la tourmente de la pandémie de COVID-19: la santé de la femme, de l’enfant et de l’adolescent dans le contexte de la couverture sanitaire universelle et des objectifs de dével...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti...
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an implementation plan.
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPC published here describes the characteristics of new types of insecticide-treated nets (ITNs) to control malaria transmission in areas with insecticide-resist...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
